Bill Cassidy of Louisiana, a physician who made it clear he was not going to vote for him if Kennedy was going to go after ...

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

The Department of Health and Human Services’ mRNA pullback only applies to their use in upper respiratory disease, according ...

CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business UpdatesEntered into a definitive Purchase Agreement pursuant to which BioNTech intends to acquir ...

Wen: The HPV vaccines have very high efficacy — close to 100% — for the prevention of cervical cancer in women, according to the CDC. The vaccines have also been found to have very high efficacy in ...

Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company focused on providing nucleic acid production solutions for the biopharmaceutical and diagnostics ...

The Trump administration’s COVID-revenge campaign has laid the groundwork for Kennedy’s larger agenda.

The medical community is expressing alarm over recent reductions in mRNA vaccine research funding, particularly as it ...

Scientists are warning people that it isn't just covid vaccines that will be affected. In other vaccine news: RFK Jr.'s criticisms of the hepatitis B vaccine; updates on Vinay Prasad; and successful ...

HHS is slashing hundreds of millions in funding for mRNA vaccines and infectious disease treatments, but leaving the door ...

Scripps News speaks with vaccine experts who say HHS funding cuts targeting mRNA vaccines could hinder other vaccine research ...

( NewsNation) — National Institutes of Health director Jay Bhattacharya believes mRNA vaccine technology is “promising” but has failed at “earning public trust,” speaking one week after the federal ...